Management and prognosis of acute liver failure in children

Daniel D'Agostino1, Silvia Diaz, Maria Camila Sanchez

  • 1Gastroenterology-Hepatology Division, Liver-Intestinal Transplantation Center, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. daniel.dagostino@hiba.org.ar

Insights

Pediatric acute liver failure (ALF) shares common pathways and challenges despite diverse causes. This review focuses on managing intracranial hypertension, coagulopathy, and multi-system failure, aiding transplant decisions.

Area of Science:

  • Pediatric Hepatology
  • Critical Care Medicine
  • Transplantation

Background:

  • Pediatric acute liver failure (ALF) presents diverse etiologies but shares common pathophysiologic pathways.
  • Historically, ALF was often fatal before the advent of liver transplantation.

Purpose of the Study:

  • To review the mechanisms and monitoring of intracranial hypertension and coagulopathy in pediatric ALF.
  • To provide management strategies for multi-system organ failures associated with ALF.
  • To evaluate prognostic scores for guiding liver transplantation decisions and timing.

Main Methods:

  • Literature review focusing on mechanisms, monitoring, and management of pediatric ALF complications.
  • Analysis of existing prognostic scores for patient selection and transplant timing.
  • Synthesis of current best practices for multi-system organ support.

Main Results:

  • Intracranial hypertension and coagulopathy are critical, common complications requiring vigilant monitoring and management.
  • Effective management of multi-system organ failures improves outcomes in pediatric ALF.
  • Various prognostic scores exist to aid in identifying patients who will benefit most from liver transplantation.

Conclusions:

  • Despite varied causes, pediatric ALF management converges on addressing key complications like intracranial hypertension and coagulopathy.
  • Comprehensive care addressing multi-system organ failure is crucial for improving survival.
  • Prognostic scores are essential tools for optimizing the selection and timing of liver transplantation in pediatric ALF patients.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...